• News
  • SAN DIEGO
  • BioTech

Zogenix shares edge higher on 4Q sales report

Shares of Zogenix Inc. (Nasdaq: ZGNX) rose Monday after the company reported stronger-than-expected fourth-quarter sales of its injectable migraine treatment Sumavel DosePro.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!